Blog Posts (6)
May 26, 2009
One of the wealthiest of the Obama administration appointees, Dr. Margaret Hamburg, has to offload her stock pretty quickly–apparently that’s what comes from being married to a very successful hedge fund manager and holding a wide range of health and other medical related stock, says the Wall Street Journal.…
April 2, 2009
As we reported on our blog a few weeks ago, it wouldn’t be long before many medical institutions were jumping on the conflict of interest bandwagon.…
January 26, 2009
The North American Spine Society has announced that researchers must disclose not only that they receive money from medical device makers but also the sum of those consulting fees, reports the Wall Street Journal.…
December 8, 2008
After the Cleveland Clinic announced last week that it would disclose all of its physician’s financial relationships with pharmaceutical companies, other hospitals are following suit as not to be left behind on the ethics bandwagon.…
October 14, 2008
Disclosing financial conflicts of interest to potential research subjects does not effect their willingness to participate in research, found a recent Johns Hopkins, Duke, and Wake Forest University study.…
March 30, 2008
Scott Haig, an orthopedist, writing in Time about the conflicts of interest that surfaced at the recent annual meeting of the American Academy of Orthopaedic Surgeons:
The DOJ’s slap was felt acutely by everyone at the convention.…
April 30, 2013 12:39 pm
Twice this past week, the US Department of Justice filed lawsuits alleging Novartis paid kickbacks to boost prescriptions and caused federal healthcare programs to pay for medicines based on false claims.
April 9, 2013 4:14 pm
A St. Louis Police Sergeant is suing his department, alleging that officials have tried to suppress his free-speech by blocking his pro-marijuana reform lobbying.
April 9, 2013 4:11 pm
While only four medical schools ban sales representatives from campus, the majority of U.S. medical schools have implemented strong conflict-of-interest policies this year, according to the 2013 American Medical Student Association (AMSA) PharmFree Scorecard.
March 7, 2013 2:56 pm
Planned Parenthood is unfit to provide sex education materials to Texas students because the organization’s status as an abortion provider constitutes a “conflict of interest,” advocates of a state bill argued on Tuesday.
March 1, 2013 12:43 pm
Students at Brown University’s Alpert Medical School are prohibited from accepting gifts or meals from pharmaceutical companies and drug salespeople. Yet, when she was training in a primary care clinic, student Reshma Ramachandran said drug salespeople stopped by often bringing lunch for the staff.
February 4, 2013 1:18 pm
The Physician Payment Sunshine Act final rule was released this past week. The final regulations will greatly affect the entire pharmaceutical and medical device industry and applies to manufacturers of drugs, devices, biologicals, or medical supplies to report annually to the Secretary of HHS.
January 1, 2013 7:29 pm
An article about a conflict of interest between drug companies, the studies they fund and the abundance of painkiller prescriptions.
November 30, 2012 2:30 pm
According to allegations made in a recent $276 million insider trading fraud lawsuit, an enterprising trader looking for a nugget of inside information can hire an “expert network” company to offer their services to money managers. But federal authorities have said the relationships can be conduits to fraud.
November 26, 2012 5:34 pm
Over a year-long period ending in August, NEJM published 73 articles on original studies of new drugs. Of those articles, 60 were funded by a pharmaceutical company and 50 were co-written by drug company employees.
October 19, 2012 6:51 pm
StemCells Inc. has had rather a charmed relationship with California’s publicly funded stem cell program, with some $40 million in awards approved this year. Co-founded by an eminent Stanford research scientist, the firm ranks first among all corporate recipients of approved funding from CIRM, despite only collecting about $1 million a year from licensing patents and selling cell cultures.
View More News Items